loading

Maravai LifeSciences Holdings Inc Aktie (MRVI) Neueste Nachrichten

Maravai Lifesciens Hldgs Inc (MRVI) - Friday, Feb 16, 2024 - Value Investors Club - Smartkarma

pulisher
Smartkarma

Maravai (MRVI) Advances in RNA Research With New Collaboration

pulisher
Zacks Investment Research

Maravai (MRVI) Advances in RNA Research With New Collaboration - Zacks Investment Research

pulisher
Zacks Investment Research

Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI) - MarketBeat

pulisher
MarketBeat

Maravai LifeSciences Sees Unusually Large Options Volume (NASDAQ:MRVI) - Defense World

pulisher
Defense World

National Bank of Canada FI Grows Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat

pulisher
MarketBeat

Trading (MRVI) With Integrated Risk Controls - Stock Traders Daily

pulisher
Stock Traders Daily

Revenues Tell The Story For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) As Its Stock Soars 25% - Simply Wall St

pulisher
Simply Wall St

ZimVie Inc. (ZIMV) Stock Jumps 20.6%: Will It Continue to Soar? - Yahoo Movies UK

pulisher
Yahoo Movies UK

Healthy Upside Potential: Maravai LifeSciences Holdings Inc (MRVI) – Sete News - SETE News

pulisher
SETE News

Robert W. Baird Raises Maravai LifeSciences (NASDAQ:MRVI) Price Target to $10.00 - Defense World

pulisher
Defense World

Monaco Asset Management SAM Takes Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat

pulisher
MarketBeat

Maravai LifeSciences Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St

pulisher
Simply Wall St

Maravai LifeSciences Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

pulisher
Yahoo Finance

Maravai LifeSciences Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

pulisher
Yahoo Finance

Maravai LifeSciences (NASDAQ:MRVI) Trading Up 6% on Analyst Upgrade - Defense World

pulisher
Defense World

Exclusive-Vaccine reagent vendor Maravai draws private equity interest-sources - Yahoo Movies Canada

pulisher
Yahoo Movies Canada

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q1 2024 Earnings Call Transcript - Yahoo Finance

pulisher
Yahoo Finance

Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule - GlobeNewswire

pulisher
GlobeNewswire

Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule - Yahoo Finance

pulisher
Yahoo Finance

Maravai LifeSciences (NASDAQ:MRVI) Trading 6% Higher Following Analyst Upgrade - MarketBeat

pulisher
MarketBeat

Earnings call: Maravai LifeSciences beats Q1 expectations, eyes growth - Investing.com

pulisher
Investing.com

Robert W. Baird Boosts Maravai LifeSciences (NASDAQ:MRVI) Price Target to $10.00 - MarketBeat

pulisher
MarketBeat

Where Maravai LifeSciences Stands With Analysts - Maravai LifeSciences (NASDAQ:MRVI) - Benzinga

pulisher
Benzinga

Maravai LifeSciences Holdings Inc (MRVI) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and ... - GuruFocus.com

pulisher
GuruFocus.com

Maravai LifeSciences (MRVI) Q1 2024 Earnings Call Transcript

pulisher
The Motley Fool

Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule - Yahoo Finance

pulisher
Yahoo Finance

Maravai LifeSciences Holdings, Inc. 2024 Q1 - Results - Earnings Call Presentation (NASDAQ:MRVI) - Seeking Alpha

pulisher
Seeking Alpha

Maravai LifeSciences Reports First Quarter 2024 Financial Results - 08.05.2024 - wallstreet:online

pulisher
wallstreet:online

Maravai LifeSciences Reports First Quarter 2024 Financial Results - Yahoo Finance

pulisher
Yahoo Finance

Analysts Set Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Target Price at $11.56 - MarketBeat

pulisher
MarketBeat

(MRVI) Trading Advice - Stock Traders Daily

pulisher
Stock Traders Daily

Federated Hermes Inc. Trims Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat

pulisher
MarketBeat

Federated Hermes Inc. Trims Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat

pulisher
MarketBeat

TriLink BioTechnologies and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap mRNA ... - Marketscreener.com

pulisher
Marketscreener.com

Maravai LifeSciences (MRVI) Scheduled to Post Quarterly Earnings on Wednesday - MarketBeat

pulisher
MarketBeat

Sivik Global Healthcare LLC Acquires New Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat

pulisher
MarketBeat

Cwm LLC Sells 8899 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World

pulisher
Defense World

TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production - Marketscreener.com

pulisher
Marketscreener.com

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024

pulisher
GlobeNewswire Inc.

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024 - Yahoo Finance

pulisher
Yahoo Finance

BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday

pulisher
Benzinga

BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday - BlackBerry (NYSE:BB - Benzinga

pulisher
Benzinga

An Intrinsic Calculation For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Suggests It's 23% Undervalued - Simply Wall St

pulisher
Simply Wall St

Should You Sell Maravai LifeSciences (MRVI)? - Yahoo Finance

pulisher
Yahoo Finance

Maravai LifeSciences Announces March 2024 Investor Conference Schedule

pulisher
GlobeNewswire Inc.

Maravai LifeSciences Announces March 2024 Investor Conference Schedule - Yahoo Finance

pulisher
Yahoo Finance

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stocks Shoot Up 28% But Its P/S Still Looks Reasonable - Simply Wall St

pulisher
Simply Wall St

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Just Released Its Annual Results And Analysts Are Updating ... - Yahoo Finance

pulisher
Yahoo Finance

Nasdaq Edges Lower; AXT Shares Surge After Q4 Results

pulisher
Benzinga
$77.56
price up icon 0.77%
$149.40
price down icon 1.20%
$29.98
price up icon 1.11%
$172.85
price up icon 1.06%
$365.81
price down icon 2.87%
$90.61
price down icon 2.55%
Kapitalisierung:     |  Volumen (24h):